Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocular Therapeutix (OCUL) Change in Account Payables (2016 - 2026)

Ocular Therapeutix has reported Change in Account Payables over the past 14 years, most recently at $3.7 million for Q1 2026.

  • For Q1 2026, Change in Account Payables rose 53028.57% year-over-year to $3.7 million; the TTM value through Mar 2026 reached $2.8 million, up 240.97%, while the annual FY2025 figure was -$887000.0, 178.93% down from the prior year.
  • Change in Account Payables for Q1 2026 was $3.7 million at Ocular Therapeutix, up from -$1.4 million in the prior quarter.
  • Over five years, Change in Account Payables peaked at $3.7 million in Q1 2026 and troughed at -$2.4 million in Q2 2024.
  • A 5-year average of $145647.1 and a median of $247000.0 in 2023 define the central range for Change in Account Payables.
  • Biggest five-year swings in Change in Account Payables: tumbled 1308.04% in 2025 and later skyrocketed 53028.57% in 2026.
  • Year by year, Change in Account Payables stood at -$1.1 million in 2022, then skyrocketed by 158.47% to $656000.0 in 2023, then tumbled by 82.93% to $112000.0 in 2024, then tumbled by 1308.04% to -$1.4 million in 2025, then surged by 374.87% to $3.7 million in 2026.
  • Business Quant data shows Change in Account Payables for OCUL at $3.7 million in Q1 2026, -$1.4 million in Q4 2025, and -$1.3 million in Q3 2025.